Author: Nakashima, Kazuki; Yanagihara, Toyoshi; Ishida, Sae; Ogo, Naruhiko; Egashira, Ayaka; Asoh, Tatsuma; Maeyama, Takashige
Title: Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases Cord-id: cdc2ko06 Document date: 2021_3_9
ID: cdc2ko06
Snippet: We describe three cases of acute exacerbation of interstitial lung diseases (ILDs) in which patients were treated with pulsed-doses of corticosteroids followed by nintedanib and maintenance doses of corticosteroids. All cases responded well to pulsed-dose corticosteroids. However, in conventional practice, corticosteroids can complicate adverse events, including opportunistic infections, diabetes, and osteoporosis. One of the cases reported here involved dermatomyositis-associated ILD with anti-
Document: We describe three cases of acute exacerbation of interstitial lung diseases (ILDs) in which patients were treated with pulsed-doses of corticosteroids followed by nintedanib and maintenance doses of corticosteroids. All cases responded well to pulsed-dose corticosteroids. However, in conventional practice, corticosteroids can complicate adverse events, including opportunistic infections, diabetes, and osteoporosis. One of the cases reported here involved dermatomyositis-associated ILD with anti-EJ antibodies. Considering possible side effects of corticosteroids and the frequent recurrence of ILDs associated with anti-EJ antibodies, we decided to use nintedanib as a sequential treatment for acute exacerbation of ILDs. Nintedanib has just been approved for treatment of progressive fibrosing ILD, but to date, few reports of acute exacerbation of ILDs treated with nintedanib have been published. This case series may contribute to a more thorough discussion regarding the use and timing of nintedanib in treating acute exacerbation of ILDs.
Search related documents:
Co phrase search for related documents- acute exacerbation and long period: 1
- acute exacerbation and long term corticosteroid treatment: 1
- acute exacerbation and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- acute exacerbation and lung field: 1, 2
- acute exacerbation and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute phase and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute phase and admission follow: 1, 2, 3
- acute phase and admission month: 1, 2
- acute phase and long period: 1, 2, 3
- acute phase and low dosage: 1
- acute phase and low incidence: 1, 2
- acute phase and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- acute phase and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
Co phrase search for related documents, hyperlinks ordered by date